These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26349241)

  • 41. [Antiapoptotic gene bcl-2 prevents cellular senescence program reactivation induced by histone deacetylase inhibitor sodium butyrate in E1A and cHa-ras transformed rat fibroblasts].
    Gordeev SA; Bykova TV; Zubova SG; Aksenov ND; Pospelova TV
    Tsitologiia; 2015; 57(2):135-43. PubMed ID: 26035971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
    Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts.
    Jackson JG; Pereira-Smith OM
    Cancer Res; 2006 Sep; 66(17):8356-60. PubMed ID: 16951143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of the TCF phosphorylation state and the chromatin structure in the negative transcription regulation of the c-fos proto-oncogene in E1A + c-Ha-ras transformed cells].
    Abramova MV; Kukushkin AN; Pospelova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 2002; 36(1):66-75. PubMed ID: 11862715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence.
    Tront JS; Hoffman B; Liebermann DA
    Cancer Res; 2006 Sep; 66(17):8448-54. PubMed ID: 16951155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gadd45 in stress signaling, cell cycle control, and apoptosis.
    Salvador JM; Brown-Clay JD; Fornace AJ
    Adv Exp Med Biol; 2013; 793():1-19. PubMed ID: 24104470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of DNA demethylation in normal and cancerous cell lines and the regulatory role of cell cycle proteins in human DNA demethylase activity.
    Vairapandi M
    J Cell Biochem; 2004 Feb; 91(3):572-83. PubMed ID: 14755686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase inhibitor sodium butyrate enhances cellular radiosensitivity by inhibiting both DNA nonhomologous end joining and homologous recombination.
    Koprinarova M; Botev P; Russev G
    DNA Repair (Amst); 2011 Sep; 10(9):970-7. PubMed ID: 21824827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
    Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
    Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of caspase-11 expression by histone deacetylase inhibitors.
    Heo H; Yoo L; Shin KS; Kang SJ
    Biochem Biophys Res Commun; 2009 Jan; 378(1):79-83. PubMed ID: 19013432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
    Toyooka T; Ibuki Y
    Cancer Res; 2009 Apr; 69(8):3492-500. PubMed ID: 19351858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
    Chiou SK; Hodges A; Hoa N
    J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response.
    Kato K; Kuhara A; Yoneda T; Inoue T; Takao T; Ohgami T; Dan L; Kuboyama A; Kusunoki S; Takeda S; Wake N
    Mol Cancer Ther; 2011 Aug; 10(8):1430-9. PubMed ID: 21632462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antiapoptotic oncogene bcl-2 induces a program of senescence in E1A + c-Ha-ras-transformants treated with adriamycin].
    Neliudova AM; Zubova SG; Aksenov ND; Pospelov VA; Pospelova TV
    Tsitologiia; 2005; 47(10):907-16. PubMed ID: 16711390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
    Götze S; Coersmeyer M; Müller O; Sievers S
    Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y.
    Hirose T; Sowa Y; Takahashi S; Saito S; Yasuda C; Shindo N; Furuichi K; Sakai T
    Oncogene; 2003 Oct; 22(49):7762-73. PubMed ID: 14586402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.